InvestSMART

Sonic Healthcare Limited (ASX:SHL)

ALERT: Price-sensitive ASX Announcement for SHL
Current share price for SHL : $21.220 -7.52 (-26.17%)+
Announcement
Release
21 Aug 2025 9:11AM
Price at Release
$28.740
Full Release
download
Summary
Sonic Healthcare Limited reported an 8% increase in revenue for the fiscal year ending 30 June 2025, reaching A$9,645 million. The company achieved its EBITDA earnings guidance with A$1,702 million in constant currency, alongside a 5% organic revenue growth and a 40bps expansion in normalized EBITDA margins. Net profit increased by 7% to A$514 million. Sonic Healthcare anticipates strong earnings growth in FY 2026, driven by organic growth, synergies from recent acquisitions in Switzerland and Germany, and strategic initiatives in the US. The company's debt cover ratio approximates pre-pandemic levels following key acquisitions, and future outlook includes robust EPS growth supported by a solid management team and market-leading brands.
Key Points
  • EBITDA earnings guidance achieved with A$1,702 million in constant currency.
  • Organic revenue growth of 5% and an expansion in normalised EBITDA margin by 40bps.
  • Sonic Healthcare's revenue for FY 2025 was A$9,645 million, an increase of 8%.
  • The company's net profit for FY 2025 was A$514 million, a 7% increase from the previous year.
  • Sonic Healthcare expects strong FY 2026 earnings growth driven by organic growth, synergies from Swiss and German acquisitions, and US initiatives.
  • The company's debt cover ratio approximates pre-pandemic average after LADR (Germany) and Cairo Diagnostics (USA) acquisitions.
  • Sonic Healthcare's Australian operations showed 6% organic revenue growth, with new contracts from private hospitals and renewals in national screening programs.
  • In Germany, Sonic completed several mergers and acquisitions, contributing to revenue growth.
  • Switzerland operations were rebranded to 'Sonic Suisse', highlighting strong management integration from recent acquisitions.
  • Outlook for FY 2026 includes strong EPS growth, supported by market-leading brands and stable, experienced management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.